Build, I think the basic trial protocol was commented on, but an official IND approval has not been received yet. I believe NGIO uses the comments and puts together the protocol they will officially submit, so I don't believe it's been submitted yet.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.